Related Experiment Video
Updated: Jun 22, 2026
High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells
Published on: April 21, 2022
Neurotoxin quantum dot conjugates detect endogenous targets expressed in live cancer cells
Rebecca L Orndorff1, Sandra J Rosenthal
1Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37235-1822, USA.
Abstract:
High affinity peptide neurotoxins are effective agents for integrating technological advances with biological inquiries. Both chlorotoxin (CTX) and dendrotoxin-1 (DTX-1) are peptide neurotoxins demonstrated to bind targets expressed by glioma cancer cells and are suitable ligands for quantum dot (QD) live cell investigations. Here, we present dual labeling of endogenously expressed cellular proteins within living cells utilizing high affinity peptide neurotoxins conjugated to QDs. Multiplexing experiments reveal quantifiable evidence that CTX and DTX-1 conjugated QDs may potentially be used as a live assessment of markers toward identification of cancer cell presence.
Insights
High affinity peptide neurotoxins, chlorotoxin (CTX) and dendrotoxin-1 (DTX-1), conjugated to quantum dots (QDs), enable dual labeling of cellular proteins. This technique offers a novel live assessment for identifying cancer cell presence.
Area of Science:
- Biotechnology
- Neuroscience
- Cancer Research
Background:
- High-affinity peptide neurotoxins are valuable tools for biological research.
- Chlorotoxin (CTX) and dendrotoxin-1 (DTX-1) target glioma cancer cells.
- Quantum dots (QDs) are suitable for live cell imaging.
Purpose of the Study:
- To develop a dual-labeling method for endogenous cellular proteins in living cells.
- To investigate the use of peptide neurotoxin-conjugated QDs for cancer cell detection.
Main Methods:
- Conjugating high-affinity peptide neurotoxins (CTX and DTX-1) to quantum dots (QDs).
- Performing dual labeling of endogenously expressed cellular proteins within living cells.
- Utilizing multiplexing experiments to quantify QD binding.
Main Results:
- Demonstrated successful dual labeling of cellular proteins using neurotoxin-QD conjugates.
- Obtained quantifiable evidence of CTX and DTX-1 QD binding to cancer cell targets.
- Showcased the potential for live assessment of cancer markers.
Conclusions:
- Peptide neurotoxin-conjugated QDs offer a promising approach for dual-labeling cellular proteins.
- This method may serve as a novel live assessment tool for identifying cancer cell presence.
- Further research can explore the application of this technique in cancer diagnostics.
